Contrast Enhanced Sonography Shows Superior Microvascular Renal Allograft Perfusion in Patients Switched From Cyclosporine A to Everolimus
Authors:
- Lars P. KihmLKLars P. Kihm
- Ulrich-Paul HinkelUHUlrich-Paul Hinkel
- Kayla MichaelKMKayla Michael
- Claudia SommererCSClaudia Sommerer
- Joerg SeckingerJSJoerg Seckinger
- Christian MorathCMChristian Morath
- Martin ZeierMZMartin Zeier
- Vedat SchwengerVSVedat Schwenger
- 27 July 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 88 (2) , 261-265
Abstract
Real-time contrast enhanced sonography (CES) provides quantitative information on microvascular tissue perfusion in renal allografts. In contrast to calcineurin inhibitors, mammalian target of rapamycin inhibitors may have beneficial effects on renal microvascular tissue perfusion. There is no information on the microperfusion of renal allografts in patients receiving either mammalian target of rapamycin inhibitor or calcineurin inhibitor. In a prospective randomized, clinical trial, renal parenchymal tissue perfusion of 24 stable renal allograft recipients was evaluated with CES. Eleven patients were kept on cyclosporine A (CsA); 13 were converted to everolimus (EVR). Measurements were made at the time of the switch from CsA to EVR, 8.21±6.36 months posttransplantation, and 21.2±6.57 months posttransplantation. In addition to laboratory and clinical parameters, Doppler indices and estimated glomerular filtration rate (eGFR) were measured. After the switch from CsA to EVR, microvascular perfusion in the EVR-treated patients (A×β value at baseline 9.23±7.44 dB/sec, A×β value at time of follow-up 19.6±13.0 dB/sec, P=0.03) and the estimated GFR (81.2±20.3 and 96.9±22.6 mL/min, P=0.001) improved significantly. Microvascular perfusion (A×β 7.04±5.32 dB/sec and A×β 8.66±9.01 dB/sec, P=0.34) and the eGFR of the group continuing CsA treatment remained stable (78.5±25.9 and 73.2±37.3 mL/min, P=0.1). The study demonstrates that renal microperfusion visualized by CES based on microbubble contrast agent and concomitantly kidney function, improved significantly after the switch from CsA to EVR.Keywords
This publication has 26 references indexed in Scilit:
- Conversion From a Calcineurin Inhibitor-Based Immunosuppressive Regimen to Everolimus in Renal Transplant Recipients: Effect on Renal Function and ProteinuriaTransplantation Proceedings, 2007
- Color Doppler Indices of Renal Allografts Depend on Vascular Stiffness of the Transplant RecipientsAmerican Journal of Transplantation, 2006
- Color Doppler Ultrasonography in the Diagnostic Evaluation of Renal AllograftsNephron Clinical Practice, 2006
- Real-Time Contrast-Enhanced Sonography of Renal Transplant Recipients Predicts Chronic Allograft NephropathyAmerican Journal of Transplantation, 2006
- Guidelines for the Use of Contrast Agents in Ultrasound - January 2004Ultraschall in der Medizin - European Journal of Ultrasound, 2004
- Sirolimus-Based Therapy Following Early Cyclosporine Withdrawal Provides Significantly Improved Renal Histology and Function at 3 YearsAmerican Journal of Transplantation, 2004
- Cyclosporin A Toxicity of the Renal Allograft – a Late Complication and Potentially ReversibleNephron, 2002
- The changing causes of graft loss and death after kidney transplantationTransplantation, 2002
- Report of the radionuclides in nephrourology committee for evaluation of transplanted kidney (review of techniques)Seminars in Nuclear Medicine, 1999
- PREDICTING GLOMERULAR FILTRATION RATE AFTER KIDNEY TRANSPLANTATIONTransplantation, 1995